Lombard Odier Asset Management (Europe)’s Quest Diagnostics DGX Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,000	Closed	-$849K	–	253
2023 Q1	$849K	Buy	6,000 +500	+9%	+$71.5K	0.04%	235
2022 Q4	$860K	Buy	5,500 +900	+20%	+$129K	0.04%	242
2022 Q3	$564K	Hold	4,600	–	–	0.03%	244
2022 Q2	$612K	Buy	+4,600	New	+$627K	0.03%	238
2017 Q3	–	Sell	-1,929	Closed	-$214K	–	452
2017 Q2	$214K	Buy	+1,929	New	+$204K	0.01%	391
2015 Q1	–	Sell	-8,400	Closed	-$566K	–	103
2014 Q4	$566K	Buy	+8,400	New	+$530K	0.12%	104

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s DGX Position: Q2 2023 in Review

Lombard Odier Asset Management (Europe) sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 6,000 shares — an estimated $849K sold.

Lombard Odier Asset Management (Europe) first reported a position in DGX in Q4 2014 and held it in 6 quarters. The position peaked at $860K in Q4 2022. 820 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

Lombard Odier Asset Management (Europe) reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
Lombard Odier Asset Management (Europe) sold 6,000 Quest Diagnostics shares in Q2 2023, an estimated $849K.
Lombard Odier Asset Management (Europe) first reported a position in Quest Diagnostics in Q4 2014 and held it in 6 quarters.
Lombard Odier Asset Management (Europe)'s Quest Diagnostics position peaked at $860K in Q4 2022.
820 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q2 2023, filed 14 Aug 2023.